Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
about
Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicityNonalcoholic fatty liver disease as a multi-systemic diseaseTreatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight LossEnergy metabolism in the liverThe adipokine/ceramide axis: key aspects of insulin sensitizationDefect of insulin signal in peripheral tissues: Important role of ceramideSugar consumption, metabolic disease and obesity: The state of the controversyInhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol.High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ FunctionsRelationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.INDY-A New Link to Metabolic Regulation in Animals and HumansEffects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies.Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenalTranscriptional regulation of oncogenic protein kinase Cϵ (PKCϵ) by STAT1 and Sp1 proteins.Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans.Cellular mechanisms by which FGF21 improves insulin sensitivity in male miceCardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure.Targeting mitochondrial alterations to prevent type 2 diabetes--evidence from studies of dietary redox-active compounds.Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism.Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patientsMaternal factors required for oocyte developmental competence in mice: transcriptome analysis of non-surrounded nucleolus (NSN) and surrounded nucleolus (SN) oocytesHepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in miceEctopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease.Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents.LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes.OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State.Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice.Long-lasting partnership between insulin resistance and endothelial dysfunction: role of metabolic memory.DAG tales: the multiple faces of diacylglycerol--stereochemistry, metabolism, and signalingFatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism.The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.Increased bioactive lipids content in human subcutaneous and epicardial fat tissue correlates with insulin resistanceSecond-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistanceRole of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in ratsRestoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa rats.Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
P2860
Q26740087-15B77DAA-C341-4F85-9D73-5C72065EB1A4Q26749290-D1C0B5E3-BEEA-4175-A060-D0AE9F52AE7AQ26775632-3F76338E-551F-439C-964F-6683873858B5Q26996783-C347C950-CD73-42AC-AE1C-D2AC26C951B9Q27025041-BE3E9E85-0F32-4541-92D4-D78D61E7F318Q27690875-C1224D89-1DE6-4AA9-B781-B4B8D83E4BACQ27968233-686938E0-6061-4CD7-98A1-C4D8211527EEQ30301111-25BDACA2-3A13-4048-94AD-A4E4F97BE5CFQ33616618-805614FA-5B4F-4EA0-B6FE-64296B8A4BFEQ33719929-6B80009D-670C-4AC1-832E-31588065BD7BQ33720338-007D69C9-A0B7-498D-B8A4-A892357E1E79Q33749608-830DFDE1-4888-456E-BAA2-BBD62D9CCD2DQ33789323-971792A3-F840-4503-87B5-36930AB46387Q33790988-4AA035D7-906D-4B72-9206-FF2AF174149FQ33888667-414015FD-40D6-434A-A69E-5194FB4EBA22Q33976547-44769A18-B301-4D36-9A57-737FAF4CB1BDQ34350772-2F931D7F-966D-48D7-9C12-D93A08F46702Q34396881-76BF9DE1-7DE4-4D93-A1DA-94F17CFAE466Q34412057-702DF2E8-8374-4676-ADDF-F16F82E4A3F0Q34449413-557EC86E-5A5A-404D-ADF3-08687765B588Q34709831-87BCF317-13F5-4C86-852D-BFD63D843FC2Q34722264-ED13E8EE-9F2D-4515-B287-353F36DF3DD8Q35073042-0DB1E038-019F-4691-A717-40B14545AE30Q35126355-B7CF26CB-3C53-4558-904C-CC1B80A34C72Q35589319-234E1DFC-BF99-4839-BF6A-F5A1072BF316Q35600641-5E5EAE6D-07FB-4A53-BE7D-1F2A45BED5D1Q35620205-A76520BD-9059-48BA-B360-572C9E5DC56DQ35630861-BE12DD91-9D42-4DE6-809C-E89EDBF8FB36Q35769283-616DFE97-FDAC-4791-BE88-3118C0B85D1FQ35938274-2D7CCDE8-9567-4E1A-8256-49201E37A2C7Q35978075-AA3C3033-8C9D-46EA-A56B-26598BB1DC02Q36074560-FECEDDB3-FBBA-413D-8FA0-53EDEFD08052Q36236384-3F350CCD-9974-4185-A1AB-55726D5BDB58Q36329899-0DABE579-B55B-40F9-8AC5-015F5F8358FCQ36408359-B93DCC1C-0AE3-4FF9-A487-CF27FDD7239AQ36570916-51C62C7E-8D95-4B75-9034-3935B5B5865AQ36583167-0973D66C-926C-4043-8B0E-4D25BE0A6173Q36684364-0DAB94C9-F2A1-48E5-96CB-4C812FA4CF65Q36720617-66C04F38-6608-4868-BD2F-74649452AC20Q36818384-5792A07D-4E3E-4F8D-B997-834AC04B178E
P2860
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
@ast
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
@en
type
label
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
@ast
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
@en
prefLabel
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
@ast
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
@en
P2860
P1433
P1476
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
@en
P2093
François R Jornayvaz
P2860
P304
P356
10.1016/J.CMET.2012.03.005
P577
2012-05-01T00:00:00Z